Common antibiotic linked to possible higher death risk
Cefepime is a fourth-generation antibiotic widely used to treat serious bacterial infections and febrile neutropenia—a fever in patients with abnormally low white blood cell counts. Unlike many antibiotics that are falling prey to antimicrobial resistance, cefepime is relatively stable against AmpC β-lactamases, giving it an advantage against bacteria that produce these enzymes. However,…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
